Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A New (Old) Treatment Option for Depression in Parkinson's Disease

A New (Old) Treatment Option for Depression in Parkinson's Disease Parkinson's disease is the most common neurodegenerative disease after Alzheimer's disease, affecting 1%–4% of people by age 80 (1). Although it is defined by motor signs, the symptoms that most impair the lives of patients—and their caregivers—are psychological symptoms, including depressed mood (2). In clinical settings, about 25% of patients with Parkinson's disease have a major depressive syndrome, and about half have clinically important depressive symptoms (2, 3). (The terminology is awkward, because according to DSM-IV-TR, a major depressive episode cannot be diagnosed if the symptoms are directly caused by a nonpsychiatric illness such as Parkinson's disease, and there is substantial evidence that the Parkinson's disease process does directly cause at least some of the depression in these patients [2]).The increased rate of depression in Parkinson's disease begins before motor impairment is evident, and it is not explained by a psychological reaction to disability (2). Depression in Parkinson's disease (4) is demonstrably different from ordinary major depression in terms of sex ratio, age, symptom profile, comorbidity, and chronicity. Pharmacotherapy for depression in Parkinson's disease entails special concerns related to side effects and drug-drug interactions. The cognitive deficits present in a substantial fraction of Parkinson's disease patients raise questions http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Psychiatry American Psychiatric Publishing, Inc (Journal)

A New (Old) Treatment Option for Depression in Parkinson's Disease

American Journal of Psychiatry , Volume 168 (10): 1015 – Oct 1, 2011

A New (Old) Treatment Option for Depression in Parkinson's Disease

American Journal of Psychiatry , Volume 168 (10): 1015 – Oct 1, 2011

Abstract

Parkinson's disease is the most common neurodegenerative disease after Alzheimer's disease, affecting 1%–4% of people by age 80 (1). Although it is defined by motor signs, the symptoms that most impair the lives of patients—and their caregivers—are psychological symptoms, including depressed mood (2). In clinical settings, about 25% of patients with Parkinson's disease have a major depressive syndrome, and about half have clinically important depressive symptoms (2, 3). (The terminology is awkward, because according to DSM-IV-TR, a major depressive episode cannot be diagnosed if the symptoms are directly caused by a nonpsychiatric illness such as Parkinson's disease, and there is substantial evidence that the Parkinson's disease process does directly cause at least some of the depression in these patients [2]).The increased rate of depression in Parkinson's disease begins before motor impairment is evident, and it is not explained by a psychological reaction to disability (2). Depression in Parkinson's disease (4) is demonstrably different from ordinary major depression in terms of sex ratio, age, symptom profile, comorbidity, and chronicity. Pharmacotherapy for depression in Parkinson's disease entails special concerns related to side effects and drug-drug interactions. The cognitive deficits present in a substantial fraction of Parkinson's disease patients raise questions

Loading next page...
 
/lp/american-psychiatric-publishing-inc-journal/a-new-old-treatment-option-for-depression-in-parkinson-s-disease-GIIJ0Bb0bz

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Psychiatric Publishing, Inc (Journal)
Copyright
Copyright © 2011 American Psychiatric Association. All rights reserved.
ISSN
0002-953X
eISSN
1535-7228
DOI
10.1176/appi.ajp.2011.11071124
pmid
21969043
Publisher site
See Article on Publisher Site

Abstract

Parkinson's disease is the most common neurodegenerative disease after Alzheimer's disease, affecting 1%–4% of people by age 80 (1). Although it is defined by motor signs, the symptoms that most impair the lives of patients—and their caregivers—are psychological symptoms, including depressed mood (2). In clinical settings, about 25% of patients with Parkinson's disease have a major depressive syndrome, and about half have clinically important depressive symptoms (2, 3). (The terminology is awkward, because according to DSM-IV-TR, a major depressive episode cannot be diagnosed if the symptoms are directly caused by a nonpsychiatric illness such as Parkinson's disease, and there is substantial evidence that the Parkinson's disease process does directly cause at least some of the depression in these patients [2]).The increased rate of depression in Parkinson's disease begins before motor impairment is evident, and it is not explained by a psychological reaction to disability (2). Depression in Parkinson's disease (4) is demonstrably different from ordinary major depression in terms of sex ratio, age, symptom profile, comorbidity, and chronicity. Pharmacotherapy for depression in Parkinson's disease entails special concerns related to side effects and drug-drug interactions. The cognitive deficits present in a substantial fraction of Parkinson's disease patients raise questions

Journal

American Journal of PsychiatryAmerican Psychiatric Publishing, Inc (Journal)

Published: Oct 1, 2011

There are no references for this article.